Creo Medical Group PLC (LON:CREO – Get Free Report) insider Kevin Crofton bought 2,916,666 shares of the firm’s stock in a transaction that occurred on Monday, October 21st. The stock was bought at an average cost of GBX 24 ($0.31) per share, for a total transaction of £699,999.84 ($908,854.64).
Creo Medical Group Price Performance
Creo Medical Group stock opened at GBX 20.25 ($0.26) on Thursday. The firm has a fifty day moving average of GBX 26.46 and a 200-day moving average of GBX 31.33. The firm has a market capitalization of £73.26 million, a P/E ratio of -334.80 and a beta of 0.86. Creo Medical Group PLC has a 52-week low of GBX 19.86 ($0.26) and a 52-week high of GBX 50 ($0.65). The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96.
About Creo Medical Group
See Also
- Five stocks we like better than Creo Medical Group
- High Flyers: 3 Natural Gas Stocks for March 2022
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- What is the S&P/TSX Index?
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.